Lexicon Pharmaceuticals
Price & Volume
Stats
See more52W Range | $0.28-$1.83 |
Market Cap | $614.2M |
Shares Short | 24M |
Financials
See moreRevenue (12 Mos) | $70.8M |
Revenue Growth (YoY) | 710.4% |
Gross Profit (12 Mos) | -$4.9M |
Diluted EPS | -$0.19 |
News
See moreYahoo Finance • 17 days ago
Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement
Yahoo Finance • 2 months ago
Lexicon Pharmaceuticals Announces Publication of Preclinical Data in the Journal of the Endocrine Society on Acyl-CoA Synthetase 5 (ACSL5) Reinforcing the Scientific Rationale for LX9851
Yahoo Finance • 3 months ago
Clinical Data on Effect of Sotagliflozin on Adipose Distribution in Non-Diabetic Patients will be Presented at the 2025 Cardio Vascular Clinical Trialists Forum
Yahoo Finance • 3 months ago
Lexicon Pharmaceuticals to Participate in Two Upcoming December Investor Conferences
About
CEO | Dr. Michael S. Exton Ph.D. |
CFO | Mr. Scott M. Coiante |
Address | 2445 Technology Forest Boulevard, The Woodlands, TX, United States, 77381 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 103 |
